29 /100
MEDIUM RISK
Score updated Jul 13, 2026

ORGO — Organogenesis Holdings Inc. Dilution Risk Tracker

Track ORGO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ORGO — Get alerts when the score changes →

As of July 13, 2026, Organogenesis Holdings Inc. (ORGO) has a DilutionWatch DilutionScore of 29/100, rated MEDIUM dilution risk. Organogenesis Holdings Inc. has a market capitalization of $330.69M, 128.67M shares outstanding, 125 institutional holders tracked. Key dilution vectors include approximately 78 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ORGO.
🔔 Track ORGO — Get forecast alerts →

💹 Market Data

Market Cap$330.69M
Shares Outstanding128.67M
Float57.38M
Cash$91.38M
Debt$49.63M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 29.6% shares (2026Q1 vs prior)
125 institutional holders · 90.75M shares
#1 MORGAN STANLEY 35.05M shares
#2 Soleus Capital Management, L.P. 10.09M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 5.80M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest13.80M
Days to Cover16.3
% of Float24.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2018
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ORGO Shareholders

Organogenesis Holdings Inc. (ORGO) has a DilutionScore of 29/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for ORGO shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for ORGO in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ORGO alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track ORGO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ORGO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ORGO
📊 ORGO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ORGO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.